Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$356,202
+$28,051 QoQ
Shares Held
2,772
+1.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#2,998
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Calydon Capital holds $35,751,780 across 10 Drug Manufacturers - General names. MRK ranks #8 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
36,979 | $9,391,556 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
58,233 | $7,357,157 | |
| 3 | AMGN |
Amgen Inc
|
20,308 | $7,353,932 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
123,497 | $7,115,897 | |
| 5 | LLY |
ELI LILLY & Co
|
1,509 | $1,809,940 | |
| 6 | AZN |
Astrazeneca PLC
|
4,923 | $933,499 | |
| 7 | NVS |
Novartis AG
|
5,755 | $901,923 | |
| 8 | MRK |
Merck & Co., Inc.
This page
|
2,772 | $356,202 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $356,202 | 2,772 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $328,151 | 2,728 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $287,149 | 2,728 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $305,589 | 3,641 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $516,281 | 6,522 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,082,954 | 12,065 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $856,224 | 8,607 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $1,413,594 | 12,448 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,071,117 | 8,652 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,213,676 | 9,198 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,039,723 | 9,537 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,003,865 | 9,751 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $1,409,258 | 12,213 | Shares | Sole | 2023-08-21 | |
| 2023-03-31 | $1,320,619 | 12,413 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,622,199 | 14,621 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $1,296,192 | 15,051 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,366,547 | 14,989 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,369,168 | 16,687 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $1,254,980 | 16,375 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $483,407 | 6,436 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $482,718 | 6,207 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $585,730 | 7,598 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $283,927 | 3,471 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $305,836 | 3,687 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $279,393 | 3,613 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $280,907 | 3,651 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||